These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20410873

  • 21. Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat.
    Naiker DV, Catts SV, Catts VS, Bedi KS, Bryan-Lluka LJ.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):87-90. PubMed ID: 16730699
    [Abstract] [Full Text] [Related]

  • 22. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used.
    Schotte A, Bonaventure P, Janssen PF, Leysen JE.
    Jpn J Pharmacol; 1995 Dec 01; 69(4):399-412. PubMed ID: 8786644
    [Abstract] [Full Text] [Related]

  • 23. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J.
    Psychiatry Clin Neurosci; 2009 Aug 01; 63(4):529-37. PubMed ID: 19496999
    [Abstract] [Full Text] [Related]

  • 24. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS.
    Psychopharmacology (Berl); 2000 Jun 01; 150(2):132-40. PubMed ID: 10907666
    [Abstract] [Full Text] [Related]

  • 25. Extended treatment with typical and atypical antipsychotic drugs differential effects on the densities of dopamine D2-like and GABAA receptors in rat striatum.
    Dean B, Hussain T, Scarr E, Pavey G, Copolov DL.
    Life Sci; 2001 Aug 03; 69(11):1257-68. PubMed ID: 11521750
    [Abstract] [Full Text] [Related]

  • 26. In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO.
    Girgis RR, Xu X, Miyake N, Easwaramoorthy B, Gunn RN, Rabiner EA, Abi-Dargham A, Slifstein M.
    Neuropsychopharmacology; 2011 Mar 03; 36(4):887-95. PubMed ID: 21178982
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
    Duncan GE, Miyamoto S, Leipzig JN, Lieberman JA.
    J Pharmacol Exp Ther; 2000 Apr 03; 293(1):8-14. PubMed ID: 10734147
    [Abstract] [Full Text] [Related]

  • 28. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
    Hall H, Halldin C, Nyberg S, Farde L, Sedvall G.
    Eur Neuropsychopharmacol; 1995 Mar 03; 5(1):19-25. PubMed ID: 7542051
    [Abstract] [Full Text] [Related]

  • 29. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E.
    Encephale; 2006 Mar 03; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [Abstract] [Full Text] [Related]

  • 30. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S, Reckless GE, Nobrega JN, Fletcher PJ, Kapur S.
    Neuropsychopharmacology; 2006 Sep 03; 31(9):1854-63. PubMed ID: 16319908
    [Abstract] [Full Text] [Related]

  • 31. Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole.
    Cole JC, Field M, Sumnall HR, Goudie AJ.
    Behav Pharmacol; 2007 May 03; 18(3):185-90. PubMed ID: 17426482
    [Abstract] [Full Text] [Related]

  • 32. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P, Tallerico T.
    Mol Psychiatry; 1998 Mar 03; 3(2):123-34. PubMed ID: 9577836
    [Abstract] [Full Text] [Related]

  • 33. Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain.
    Timmerman W, Heijmen M, Westerink BH, Bruggeman R, den Boer JA.
    Psychopharmacology (Berl); 1999 Jun 03; 144(3):286-94. PubMed ID: 10435397
    [Abstract] [Full Text] [Related]

  • 34. Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.
    Tarazi FI, Moran-Gates T, Gardner MP, Graulich A, Lamy C, Liégeois JF.
    J Mol Neurosci; 2007 Jun 03; 32(3):192-8. PubMed ID: 17873364
    [Abstract] [Full Text] [Related]

  • 35. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
    Bubeníková V, Votava M, Horácek J, Pálenícek T, Dockery C.
    Pharmacol Biochem Behav; 2005 Apr 03; 80(4):591-6. PubMed ID: 15820528
    [Abstract] [Full Text] [Related]

  • 36. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
    Li M, Sun T, Zhang C, Hu G.
    Psychopharmacology (Berl); 2010 Sep 03; 212(1):45-57. PubMed ID: 20623111
    [Abstract] [Full Text] [Related]

  • 37. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine.
    Fujimura M, Hashimoto K, Yamagami K.
    Eur J Pharmacol; 2000 Jun 09; 398(1):1-10. PubMed ID: 10856442
    [Abstract] [Full Text] [Related]

  • 38. Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells.
    Vanhauwe JF, Ercken M, van de Wiel D, Jurzak M, Leysen JE.
    Psychopharmacology (Berl); 2000 Jul 09; 150(4):383-90. PubMed ID: 10958079
    [Abstract] [Full Text] [Related]

  • 39. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan 09; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 40. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.
    Roberts C, Cummins R, Gnoffo Z, Kew JN.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):108-14. PubMed ID: 16490190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.